SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1
Document Type: S-1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057939
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026057939/ea0290954-s1_synergy.htm

Chunk 10 of 16
Word Count: 1290
Character Count: 8230

Document Content:

distribute the shares of common stock registered under the Registration Statement. We are required to pay certain fees and expenses incurred by us incident to the registration of these shares of common stock. We have agreed to indemnify the Selling Stockholder against certain losses, claims, damages and liabilities, including liabilities under the Securities Act. We have also agreed to keep this prospectus effective until all of the shares of common stock have been sold pursuant to this prospectus. The shares of common stock will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the shares covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. Compliance with the Exchange Act, including Regulation M

Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the shares of common stock may not simultaneously engage
in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to
the commencement of the distribution. In addition, the Selling Stockholder will be subject to applicable provisions of the Exchange Act
and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock
by the Selling Stockholder or any other person.

DESCRIPTION OF CAPITAL STOCK

The following descriptions
are summaries of the material terms of our certificate of incorporation and amended and restated bylaws, to which you should refer. Reference
is made to the more detailed provisions of, and the descriptions are qualified in their entirety by reference to, the certificate of incorporation
and amended and restated bylaws, which are filed with the SEC as exhibits to the registration statement of which this prospectus is a
part, and applicable law.

General

Our authorized capital stock consists of 300,000,000 shares of
common stock, par value $0.00001 per share and 1,000,000 shares of undesignated preferred stock, $0.00001 par value. As of May 14,
2026, there were 15,079,956 shares of common stock issued and 14,899,883 shares of common stock outstanding, held by approximately
68 stockholders of record. As of the date of this prospectus, no shares of preferred stock were issued or outstanding. Upon completion
of this offering, there will be 116,439,883 shares of common stock outstanding, assuming the sale of all of the ELOC Shares and Warrant
Shares registered under the Registration Statement.

Common Stock

Dividend Rights

The holders of outstanding
shares of our common stock are entitled to receive dividends out of funds legally available at the times and in the amounts that our Board
of Directors may determine.

Voting Rights

Each holder of our common stock
is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Cumulative voting for
the election of directors is not provided for in our articles of incorporation, which means that the holders of a majority of our shares
of common stock voted can elect all of the directors then standing for election.

Preemptive or Similar Rights

Our common stock is not entitled
to preemptive rights and is not subject to conversion or redemption.

Liquidation Rights

Upon our liquidation, dissolution,
or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our
common stock outstanding at that time after payment of other claims of creditors.

Preferred Stock

Our articles of incorporation
provide that our Board of Directors is authorized to issue shares of preferred stock from time to time in one or more series. Our Board
of Directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional
or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our Board
of Directors is able to, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect
the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our Board of
Directors to issue preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of
control of us or the removal of existing management. We have no preferred stock outstanding at the date hereof. Although we do not currently
intend to issue any shares of preferred stock, we cannot assure you that we will not do so in the future.

Anti-Takeover Effects of Certain Provisions
of Nevada Law

Effect of Nevada Anti-takeover Statute.
We are subject to Section 78.438 of the Nevada Revised Statutes, an anti-takeover law. In general, Section 78.438 prohibits
a Nevada corporation from engaging in any business combination with any interested stockholder for a period of two years following
the date that the stockholder became an interested stockholder, unless prior to that date, the board of directors of the corporation approved
either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder, or if after the
date that the stockholder becomes an interested stockholder the business combination is approved by the board of directors and by 60%
of the voting power of all disinterested stockholders at either an annual or special meeting of the stockholders of the corporation. Section 78.439
provides that business combinations after the two-year period following the date that the stockholder becomes an interested stockholder
may also be prohibited unless either approved by the corporation’s directors before the stock acquisition, or by a majority of the
disinterested stockholders or unless the price and terms of the transaction meet other criteria set forth in the statute.

Section 78.416 defines “business
combination” to include the following:

●	any merger or consolidation involving the corporation and the
interested stockholder or any other corporation which is an affiliate or associate of the interested stockholder;

●	any sale, transfer, pledge or other disposition of the assets
of the corporation involving the interested stockholder or any affiliate or associate of the interested stockholder if the assets transferred
have a market value equal to 5% or more of all of the assets of the corporation or 5% or more of the value of the outstanding shares
of the corporation or represent 10% or more of the earning power of the corporation;

●	subject to certain exceptions, any transaction that results
in the issuance or transfer by the corporation of any stock of the corporation to an interested stockholder, with a market value of 5%
or more of the value of the outstanding shares of the corporation;

●	the adoption of a plan of liquidation proposed by or under any
arrangement with the interested stockholder or any affiliate or associate of the interested stockholder;

●	any transaction involving the corporation that has the effect
of increasing the proportionate share of the stock of any class or series of voting shares of securities convertible into voting shares
of the corporation beneficially owned by the interested stockholder or any affiliate or associate of the interested stockholder; or

●	the receipt by the interested stockholder or any affiliate or
associate of the interested stockholder of the benefit, except proportionately as a stockholder of the corporation, of any loans, advances,
guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 78.423
defines an interested stockholder as any entity or person beneficially owning, directly or indirectly, 10% or more of the outstanding
voting stock of the corporation and any entity or person affiliated with or controlling or controlled by any of these entities or persons.